Trials / Completed
CompletedNCT00632450
EnSite Real-Time Cardiac Performance Measurements (RT CPM) Study
EnSite Real-Time Cardiac Performance Measurements Study, a Non-significant Risk Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 21 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The EnSite Real-Time Cardiac Performance Measurements Study (EnSite RT CPM) is a multicenter, international, acute, non-significant risk study, designed to enroll a maximum of 40 patient. The goal of the study is to collect 3-D systolic/diastolic data with the EnSite NavX Mapping system during a CRT implant. Patients enrolled in this study will undergo NavX CPM recording of the heart using the EnSite NavX Mapping system during the implantation of a cardiac resynchronization therapy device.
Conditions
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2008-10-01
- Completion
- 2008-10-01
- First posted
- 2008-03-10
- Last updated
- 2019-02-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00632450. Inclusion in this directory is not an endorsement.